Resolution of Neuro-muscular Block in Great Obese Patients: Neostigmine vs Sugammadex

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02401841

Enrollment

Registered

2015-03-30

Start date

2015-01-31

Completion date

Unknown

Last updated

2015-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resolution of Neuromuscular Blockade

Brief summary

It is a observational prospective study. The aim of this study is to compare neostigmine vs sugammadex in the resolution of neuro-muscular blockade in great obese patients.

Interventions

DRUGTwo different types of drug for resolution of neuro-muscular blockade

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Great obese * Videolaparoscopic surgery

Exclusion criteria

* Age under 18 * No acceptation of informed consent * New York Heart Association \> 2

Design outcomes

Primary

Measure	Time frame
Differences in neuro-muscular block resolution time between two groups	up to 36 months

Countries

Italy

Contacts

Primary ContactDavide Chiumello, MD

chiumello@libero.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026